Market revenue in 2023 | USD 2,286.9 million |
Market revenue in 2030 | USD 3,010.5 million |
Growth rate | 4% (CAGR from 2023 to 2030) |
Largest segment | Topical hemostat |
Fastest growing segment | Adhesive & tissue sealant |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Topical hemostat, Adhesive & tissue sealant |
Key market players worldwide | Johnson & Johnson, Cryolife, Cohera Medical, Pfizer Inc, Becton Dickinson & Co, Baxter International Inc, HyperBranch Medical Technology, Zimmer Biomet Holdings Inc, B. Braun Medical, Smith & Nephew PLC, Advanced Medical Solutions, Integra Lifesciences Holdings Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hemostasis & tissue sealing agents market will help companies and investors design strategic landscapes.
Topical hemostat was the largest segment with a revenue share of 65.78% in 2023. Horizon Databook has segmented the U.S. hemostasis & tissue sealing agents market based on topical hemostat, adhesive & tissue sealant covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. hemostasis and tissue sealing agents market is expected to grow rapidly by 2025. Drivers responsible for growth are increasing obese & geriatric population and growing demand for sealants to avoid postoperative risk of bleeding.
Moreover, interest of market players is growing in the underpenetrated hemostasis and tissue sealing agents market, which is driving innovation and development of new products in this market. Multifunctional products such as fibrin products, which offer both tissue sealing and hemostatic properties, are expected to witness high demand in this market.
Ethicon and Baxter are two companies that provide such products. However, the FDA approval process to gain approval for such devices in the U.S is strict. For instance, Oxiplex Gel Adhesion Barrier by FzioMed is available in over 70 countries, but is yet to be approved by the U.S. FDA.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. hemostasis & tissue sealing agents market , including forecasts for subscribers. This country databook contains high-level insights into U.S. hemostasis & tissue sealing agents market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account